RE: Capita shares up by over 1,000 percent today30 Apr 2025 11:44
Biotech heating up! ImmuPharma is flying under the radar—but not for long. With game-changing assets like Lupuzor™ in the pipeline and growing interest in autoimmune treatments, this could be a sleeper stock poised for breakout.
📈 Strong IP portfolio
💊 Focused on high-need therapeutic areas
🤝 Partnerships & licensing potential
💡 Multiple catalysts expected in the near term
Low market cap. High potential. Eyes on the newsflow.
🔔 DYOR but don't sleep on IMM—momentum may just be getting started. #IMM #BiotechStocks #LupusTreatment #PharmaWatch